MeiraGTx Holdings (MGTX) Net Cash Flow (QoQ) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 492.32% |
| Sep 30, 2025 | 67.02% |
| Jun 30, 2025 | -6.67% |
| Mar 31, 2025 | -81.85% |
| Dec 31, 2024 | -185.73% |
| Sep 30, 2024 | 223.14% |
| Jun 30, 2024 | -79.76% |
| Mar 31, 2024 | -116.58% |
| Dec 31, 2023 | 326.70% |
| Sep 30, 2023 | -218.46% |
| Jun 30, 2023 | 150.73% |
| Mar 31, 2023 | -63,921.62% |
| Dec 31, 2022 | -99.82% |
| Sep 30, 2022 | 200.97% |
| Jun 30, 2022 | -79.12% |
| Mar 31, 2022 | -344.91% |
| Dec 31, 2021 | 81.93% |
| Sep 30, 2021 | -9.10% |
| Jun 30, 2021 | -175.90% |
| Mar 31, 2021 | -132.54% |
| Dec 31, 2020 | 287.09% |
| Sep 30, 2020 | -0.26% |
| Jun 30, 2020 | 2.79% |
| Mar 31, 2020 | 38.99% |
| Dec 31, 2019 | -153.52% |
| Sep 30, 2019 | 317.92% |
| Jun 30, 2019 | -114.40% |
| Mar 31, 2019 | 879.00% |
| Dec 31, 2018 | -51.15% |
| Sep 30, 2018 | -119.26% |
| Jun 30, 2018 | 193.89% |
| Mar 31, 2018 | 627.70% |
| Dec 31, 2017 | 2,243.00% |